BEGIN:VCALENDAR
PRODID:Timetable.pm james@incoherency.co.uk
VERSION:2.0
BEGIN:VTIMEZONE
TZID:Europe/London
X-LIC-LOCATION:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:19700329T010000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:19701025T020000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART:20140317T151500
DURATION:PT50M
LOCATION:5W 2.4
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30252/40252-Lecg 5W 2.4 Pharmacology of regenerative medicine
UID:14ddbc4136f3313c6abe1f27d19ba4cd@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140203T151500
DURATION:PT50M
EXDATE:20140210T151500,20140224T151500
LOCATION:5W 2.4
RRULE:FREQ=WEEKLY;COUNT=5
SUMMARY:PA30252/40252-Leca 5W 2.4 Pharmacology of regenerative medicine
UID:be3cb391b0a5f539c107bc7bddca183f@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140224T151500
DURATION:PT50M
EXDATE:20140303T151500
LOCATION:5W 2.4
RRULE:FREQ=WEEKLY;COUNT=3
SUMMARY:PA30252/40252-Lecd 5W 2.4 Pharmacology of regenerative medicine
UID:69424e6480cfb20cd4329767925da763@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140224T171500
DURATION:PT50M
LOCATION:5W 2.3
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30157/40157-Lecd 5W 2.3 The molecular biology and treatment of ca
 ncer
UID:c5c88c5264dc3e8627b0d757f75718d9@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140224T121500
DURATION:PT50M
EXDATE:20140303T121500,20140310T121500,20140317T121500,20140324T121500
LOCATION:
RRULE:FREQ=WEEKLY;COUNT=6
SUMMARY:BB-Final yr Tut s2 
UID:3145791cb0822eb993d305d6d582d7f2@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140203T141500
DURATION:PT50M
LOCATION:CB 3.5
RRULE:FREQ=WEEKLY;COUNT=11
SUMMARY:BB30067/40190-Leca CB 3.5 Advanced developmental genetics
UID:d0dc3d76a4586d1da173acfd24173b21@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140210T151500
DURATION:PT50M
LOCATION:5W 2.4
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30252/40252-Lecc 5W 2.4 Pharmacology of regenerative medicine
UID:6115b877d200597767257db4a73e5e9b@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140203T161500
DURATION:PT110M
LOCATION:8W 2.29
RRULE:FREQ=WEEKLY;COUNT=11
SUMMARY:BB40109-Sem 8W 2.29 Structural biology in biotechnology & medicine
UID:25ec7fbc7ae4ebd371c5a5705476fc15@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140203T091500
DURATION:PT110M
LOCATION:8W 2.20
RRULE:FREQ=WEEKLY;COUNT=11
SUMMARY:BB40086-Sem 8W 2.20 Molecular immunology
UID:2c3522f2622ae3f146e546c3bbca8f6e@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140203T131500
DURATION:PT50M
LOCATION:1W 3.15
RRULE:FREQ=WEEKLY;COUNT=8
SUMMARY:BB30050-Lec 1W 3.15 Biochemical problems
UID:f224498db32e264bd08cde0ab609a976@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140203T141500
DURATION:PT50M
LOCATION:1W 2.102
RRULE:FREQ=WEEKLY;COUNT=11
SUMMARY:BB40048-Leca 1W 2.102 Enzymes: mechanisms, evolution and control in
  integrated biological systems
UID:79c899c72028d110960a1addab68176d@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140310T151500
DURATION:PT50M
LOCATION:CB 4.5
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30169/40163-Lech CB 4.5 Trends in molecular signalling
UID:8e6d4903a8414ca060469cee908241b7@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140203T161500
DURATION:PT110M
EXDATE:20140421T161500,20140428T161500
LOCATION:4E 3.38
RRULE:FREQ=WEEKLY;COUNT=14
SUMMARY:MN30076-Lec 4E 3.38 Business strategy
UID:0b3e5afe43ee5e71e8a6d077db93aa30@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140408T091500
DURATION:PT50M
LOCATION:1W 3.6
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30252-Semb 1W 3.6 Pharmacology of regenerative medicine
UID:f10de8375602885b513ca489b0b7cb94@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140225T101500
DURATION:PT50M
LOCATION:6W 1.2
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30252/40252-Leci 6W 1.2 Pharmacology of regenerative medicine
UID:16903c32a0fbaaa0cac1ea8b58d16e02@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140204T161500
DURATION:PT50M
LOCATION:5W 2.3
RRULE:FREQ=WEEKLY;COUNT=3
SUMMARY:PA30157/40157-Leca 5W 2.3 The molecular biology and treatment of ca
 ncer
UID:aa616cc0ec8d9e5e0ab23b0ef28fc4d7@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140311T091500
DURATION:PT50M
LOCATION:CB 4.5
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30169/40163-Lecd CB 4.5 Trends in molecular signalling
UID:eee54009f083ea45a94edec511b540f7@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140311T101500
DURATION:PT50M
LOCATION:6W 1.2
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30252/40252-Lech 6W 1.2 Pharmacology of regenerative medicine
UID:7d36407b398fae9ffcbf3de707bc3495@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140311T171500
DURATION:PT50M
LOCATION:EB 1.1
RRULE:FREQ=WEEKLY;COUNT=3
SUMMARY:PA30157/40157-Lece EB 1.1 The molecular biology and treatment of ca
 ncer
UID:35a0b757f98207c0adb6f2ac851d7c7f@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140304T091500
DURATION:PT50M
LOCATION:CB 4.5
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30169/40163-Lecc CB 4.5 Trends in molecular signalling
UID:aaca9cd258c421c22d5bffa5e5dca928@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140304T101500
DURATION:PT50M
LOCATION:6W 1.2
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30252/40252-Lecf 6W 1.2 Pharmacology of regenerative medicine
UID:4fdbb15a946b08607b0ee8a764309cf3@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140225T091500
DURATION:PT50M
LOCATION:CB 4.5
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30169/40163-Lecb CB 4.5 Trends in molecular signalling
UID:c7b289bb66fb9a68f455b78b83fb5bea@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140218T101500
DURATION:PT50M
LOCATION:6W 1.2
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30252/40252-Lece 6W 1.2 Pharmacology of regenerative medicine
UID:be39c480d60d2a543a9f05fd421ad363@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140325T091500
DURATION:PT110M
LOCATION:CB 3.10
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30169/40163-Tuta CB 3.10 Trends in molecular signalling
UID:fb69eda0aba0acb69822ccb56f90f99f@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140204T111500
DURATION:PT110M
LOCATION:8W 2.19
RRULE:FREQ=WEEKLY;COUNT=11
SUMMARY:BB40185-Sem 8W 2.19 Synthetic biology
UID:a8994354b83df669bd16567c2ef2d65c@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140204T131500
DURATION:PT50M
LOCATION:4S 0.78
RRULE:FREQ=WEEKLY;COUNT=11
SUMMARY:BB-Ext Sem S2 4S 0.78
UID:d04a4cbc2526a785fbd8a792e2df5001@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140204T161500
DURATION:PT50M
LOCATION:3WN 3.8
RRULE:FREQ=WEEKLY;COUNT=11
SUMMARY:BB40048-Lecb 3WN 3.8 Enzymes: mechanisms, evolution and control in 
 integrated biological systems
UID:9574bfefedc3c5f9e4701540cf103d8b@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140218T091500
DURATION:PT50M
LOCATION:CB 4.5
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30169/40163-Leci CB 4.5 Trends in molecular signalling
UID:bd48da107f5551b57659624f5b8af67b@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140408T101500
DURATION:PT50M
LOCATION:6W 1.2
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30252/40252-Semb 6W 1.2 Pharmacology of regenerative medicine
UID:4b5325474f6331683c04a7e761beb1b6@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140204T091500
DURATION:PT50M
LOCATION:CB 4.5
RRULE:FREQ=WEEKLY;COUNT=2
SUMMARY:PA30169/40163-Leca CB 4.5 Trends in molecular signalling
UID:b75b466ef8b3cc3ae4ff2eb2f8dd2bf8@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140204T101500
DURATION:PT50M
LOCATION:6W 1.2
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30252/40252-Lecb 6W 1.2 Pharmacology of regenerative medicine
UID:9b2c02a3015fae6f13e93f01d8af904c@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140205T091500
DURATION:PT50M
LOCATION:6E 2.2
RRULE:FREQ=WEEKLY;COUNT=11
SUMMARY:BB30067/40190-Lecb 6E 2.2 Advanced developmental genetics
UID:c8b6db602a2a13e16e6a81bf8e772ca1@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140305T101500
DURATION:PT50M
LOCATION:CB 4.5
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30169/40163-Lecg CB 4.5 Trends in molecular signalling
UID:6e76a1ef3b38b24f573f158b9e0af961@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140226T121500
DURATION:PT50M
LOCATION:8W 1.34
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30169/40163-Lecf 8W 1.34 Trends in molecular signalling
UID:11d94cc1948c439b39cc2eaf4b43761a@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140409T111500
DURATION:PT110M
LOCATION:8W 1.34
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30169/40163-Tutc 8W 1.34 Trends in molecular signalling
UID:2a19ba2cb107b5dc404e1166e3496e65@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140402T111500
DURATION:PT110M
LOCATION:8W 1.34
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30169/40163-Tutb 8W 1.34 Trends in molecular signalling
UID:8b852e03d4d6c5a4093f5c2f783ec51c@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140206T131500
DURATION:PT50M
LOCATION:3WN 2.1
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:BB-Final yr Intro Sm 2 3WN 2.1
UID:cf0ba1c105c023b99059431ec4ad131e@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140403T151500
DURATION:PT50M
LOCATION:8W 2.29
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30252-Sema 8W 2.29 Pharmacology of regenerative medicine
UID:ec837e0055c9b3d0593d690a9d594828@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140206T161500
DURATION:PT110M
LOCATION:4E 3.38
RRULE:FREQ=WEEKLY;COUNT=11
SUMMARY:BB40139-Lec 4E 3.38 Pathogenesis and immune evasion by microbes
UID:110f2aa076a5bb143a84b73c2d15c7b1@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140206T091500
DURATION:PT110M
LOCATION:8W 2.24
RRULE:FREQ=WEEKLY;COUNT=11
SUMMARY:BB40084-Sem 8W 2.24 Cellular biochemistry
UID:71ffc029ecf5fb26537c8f1bebd230b6@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140206T111500
DURATION:PT110M
LOCATION:1W 3.6
RRULE:FREQ=WEEKLY;COUNT=11
SUMMARY:BB40085-Sem 1W 3.6 Medical biochemistry
UID:9385a27d454279ecc97f653a29135d74@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140213T141500
DURATION:PT110M
LOCATION:2E 1.14
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:BB-Final yr skills Sm2 2E 1.14
UID:d1197ad3c74bf5975bade315e75885ae@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140220T171500
DURATION:PT50M
LOCATION:8W 1.33
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30169/40163-Lecj 8W 1.33 Trends in molecular signalling
UID:472a9510f4e5e226a231a539b47959ae@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140321T161500
DURATION:PT110M
LOCATION:2E 3.1
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30157/40157-Worka/all 2E 3.1 The molecular biology and treatment 
 of cancer
UID:dd29129a8c20e0c65308c7a2111caf6f@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140221T131500
DURATION:PT50M
EXDATE:20140228T131500,20140307T131500
LOCATION:5W 2.3
RRULE:FREQ=WEEKLY;COUNT=4
SUMMARY:PA30157/40157-Lecc 5W 2.3 The molecular biology and treatment of ca
 ncer
UID:28567e2e48d391f06b9620d77f3c6f70@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140404T161500
DURATION:PT110M
LOCATION:5W 2.3
RRULE:FREQ=WEEKLY;COUNT=1
SUMMARY:PA30157/40157-Workb/all 5W 2.3 The molecular biology and treatment 
 of cancer
UID:58eac1a06fd3f7998d6892056b2d25e4@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140207T111500
DURATION:PT110M
LOCATION:8W 1.34
RRULE:FREQ=WEEKLY;COUNT=10
SUMMARY:BB40164-Sem 8W 1.34 Modern methods of researching neurodegeneration
UID:80c7c5c39077e9db818d5a19ca41add3@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140207T131500
DURATION:PT50M
EXDATE:20140221T131500,20140228T131500
LOCATION:5W 2.3
RRULE:FREQ=WEEKLY;COUNT=5
SUMMARY:PA30157/40157-Lecb 5W 2.3 The molecular biology and treatment of ca
 ncer
UID:6fc394b68973c2583a1e5d2370ef5671@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140207T141500
DURATION:PT110M
LOCATION:CB 3.1
RRULE:FREQ=WEEKLY;COUNT=10
SUMMARY:BB30169-Lec CB 3.1 Concepts in systems biology
UID:6b9500becebe3e8231d64813324b76c0@notlate.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART:20140207T161500
DURATION:PT50M
LOCATION:CB 4.5
RRULE:FREQ=WEEKLY;COUNT=2
SUMMARY:PA30169/40163-Lece CB 4.5 Trends in molecular signalling
UID:1048618f4abe7a143a9eac899ad18216@notlate.co.uk
END:VEVENT
END:VCALENDAR
